Policy for Monkeypox Tests to Address the Public Health Emergency: Guidance for Laboratories, Commercial Manufacturers and Food and Drug Administration Staff
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 7, 2022
September 13, 2022
2668bb56-8427-4f20-97ac-6db37d1f5d0b
Related Documents
Consideration of Enforcement Policies for In Vitro Diagnostic Tests During a Section 564 Declared Emergency: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentSeptember 23, 2025Center for Devices and Radiological Health
Technical Performance Assessment of Quantitative Imaging in Radiological Device Premarket Submissions: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentJune 16, 2022Center for Devices and Radiological Health
General Wellness: Policy for Low Risk Devices: Guidance for Industry and Food and Drug Administration Staff
Guidance DocumentSeptember 27, 2019Center for Devices and Radiological Health
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox